{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/pharmgkb",
      "@type": "sc:SoftwareApplication",
      "edam:has_input": {
        "@id": "edam:data_2649"
      },
      "edam:has_output": {
        "@id": "edam:data_0916"
      },
      "sc:additionalType": [
        "Web application",
        "Database portal"
      ],
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0625"
        },
        {
          "@id": "edam:topic_0202"
        },
        {
          "@id": "edam:topic_2815"
        },
        {
          "@id": "edam:topic_0208"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1038/clpt.2012.96"
        },
        "pmcid:PMC3660037",
        "pubmed:22992668"
      ],
      "sc:description": "Database on the impact of human genetic variations on drug response. PharmGKB curates primary genotype and phenotype data, annotate gene variants and gene-drug-disease relationships via literature review, and summarize important PGx genes and drug pathways.",
      "sc:featureList": {
        "@id": "edam:operation_0224"
      },
      "sc:license": "CC-BY-NC-SA-4.0",
      "sc:name": "PharmGKB",
      "sc:url": "http://www.pharmgkb.org"
    },
    {
      "@id": "https://doi.org/10.1038/clpt.2012.96",
      "@type": "sc:CreativeWork"
    }
  ]
}